ArticleBreast cancer research and treatment2022

Average duration of prior treatment lines predicts clinical benefit to eribulin chemotherapy in patients with metastatic breast cancer.

Faye Coe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.